Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease

Bressler Brian; Panaccione Remo; Fedorak Richard N; Seidman Ernest G

首页> 外文期刊>ISRN Hypertension >Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease

【24h】

Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease

机译：临床医生使用粪便钙卫蛋白来识别和监测炎症性肠病中疾病活动的指南

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND Objective monitoring of the severity of inflammation in patients with inflammatory bowel disease (IBD) is an essential part of disease management. However, repeat endoscopy to define extent and severity of inflammation is not practical. Fecal calprotectin (FC) is a biomarker that can be used as a surrogate test to distinguish inflammatory from noninflammatory gastrointestinal disease.

机译：背景技术对炎症性肠病（IBD）患者的炎症严重程度进行客观监测是疾病管理的重要组成部分。然而，重复内窥镜检查来确定炎症的程度和严重性是不切实际的。粪钙卫蛋白（FC）是一种生物标志物，可以用作替代测试，以区分炎症性疾病和非炎症性胃肠疾病。

著录项

来源
《ISRN Hypertension》 |2015年第7期|共4页
作者
Bressler Brian; Panaccione Remo; Fedorak Richard N; Seidman Ernest G;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Clinicians' guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease [J] . Bressler Brian, Panaccione Remo, Fedorak Richard N., Canadian journal of gastroenterology . 2015,第7期

机译：临床医生使用粪便钙卫蛋白鉴定和监测炎性肠病中疾病活动的指南
2. Erratum: EMerging BiomARKers in inflammatory bowel disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for crohn's disease activity: Role of cross-sectional imaging (American Journal of Gastroenterology (2013) 108 (1891-1900) DOI: 10.1038/ajg.2013.354) [J] . FaubionW.A., FletcherJ.G., OByrneS., The American Journal of Gastroenterology . 2014,第5期

机译：勘误表：在炎症性肠病中出现新兴生物mARKers（EMBARK）研究发现粪便钙卫蛋白，血清MMP9和血清IL-22是克罗恩病活性的生物标志物的新组合：横断面成像的作用（美国胃肠病学杂志（2013）108 （1891-1900）DOI：10.1038 / ajg.2013.354）
3. Emerging biomarkers in inflammatory bowel disease (embark) study identifies fecal calprotectin, serum mmp9, and serum il-22 as a novel combination of biomarkers for crohn's disease activity: Role of cross-sectional imaging [J] . FaubionW.A., FletcherJ.G., OByrneS., The American Journal of Gastroenterology . 2013,第12期

机译：炎症性肠病（腹部）研究中的新兴生物标志物将粪便钙卫蛋白，血清mmp9和血清il-22鉴定为克罗恩病活性的生物标志物的新型组合：横截面成像的作用
4. Potential role of thermography in evaluation of disease activity in inflammatory bowel disease — A case report [C] . Banic Marko, Kolanc Darko, Antonini Svetlana, 53rd International Symposium ELMAR-2011 . 2011

机译：热成像在评估炎症性肠病疾病活动中的潜在作用-病例报告
5. Serum and Fecal Biomarkers Predict Response to Infliximab Therapy in Pediatric Patients with Inflammatory Bowel Disease [D] . Kim, Jochebed. 2020

机译：血清和粪便生物标志物预测对炎症肠病小儿患者的英夫利昔单抗疗法的反应
6. Clinicians’ guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease [O] . Brian Bressler, Remo Panaccione, Richard N Fedorak, 2015

机译：临床医生使用粪便钙卫蛋白来识别和监测炎症性肠病中疾病活动的指南
7. Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease [O] . Brian Bressler, Remo Panaccione, Richard N Fedorak, 2015

机译：临床医生使用粪便钙保护菌素的指南，以识别和监测炎症性肠病的疾病活动

Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease

摘要

著录项

相似文献

相关主题

期刊订阅